X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EM | 2025-12-26 | MRUS | Genmab A/S | 10% | P - Purchase | $1.33 | +76,922,983 | 0 | -100% | +$102,411,145 | |||||
| M | 2025-12-22 | MRUS | Genmab A/S | 10% | P - Purchase | $97.00 | +815,444 | 72,828,509 | +1% | +$79,098,068 | |||||
| M | 2025-12-18 | MRUS | Genmab A/S | 10% | P - Purchase | $97.00 | +278,441 | 72,013,065 | 0% | +$27,008,777 | |||||
| M | 2025-12-16 | MRUS | Genmab A/S | 10% | P - Purchase | $97.00 | +271,547 | 71,734,624 | 0% | +$26,340,059 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |